Index Entries

1151 Results
TitleIS Publication Date
New COVID Select Memo Details Allegations of Wrongdoing and Illegal Activity by Dr. Fauci’s Senior Scientific AdvisorMay 22, 2024
New COVID-19 Treatments Add-On Payment (NCTAP)Last modified December 13, 2022
New report on UK excess deaths
New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us aboutNovember 9, 2021
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 VaccinationSeptember 28, 2022
New-onset autoimmune phenomena post-COVID-19 vaccinationDecember 27, 2021
New-onset psychosis following COVID-19 vaccination: a systematic reviewApril 12, 2024
News release: FDA Approves First COVID-19 VaccineAugust 23, 2021
News release: FDA Approves First Treatment for COVID-19October 22, 2020
News release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 VaccineDecember 18, 2020
NHS key statistics: EnglandNovember 15, 2023
NIH Documents Provide New Evidence U.S. Funded Gain-of-Function Research in WuhanSeptember 9, 2021
Ninety-third SAGE meeting on COVID-19July 7, 2021
Ninth Amendment to Declaration Under the Public Readiness and Emergency Preparedness (PREP} Act for Medical Countermeasures Against COVID-19September 14, 2021
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayDecember 10, 2021
No learning loss in Sweden during the pandemic: Evidence from primary school reading assessmentsJune 2, 2022
Nobel Laureate Luc Montagnier - Warns Covid Vaccine May Lead to 'Neurodegenerative Illness'May 27, 2021
Non-COVID Excess Deaths, 2020-21: Collateral Damage of Policy Choices?June 2022
Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemicOctober 10, 2020
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza2019
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)January 8, 2021
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental MeasuresMay 2020
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021September 23, 2021
NSW COVID-19 Weekly Data Overview: Epidemiological weeks 51 and 52, ending 31 December 2022December 31, 2022
Off-label prescribingDecember 2, 2013
Official mortality data for England suggest systematic miscategorisation of vaccine status and uncertain effectiveness of Covid-19 vaccinationJanuary 12, 2022
On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination
On the use of the Pfizer and the Moderna COVID-19 mRNA vaccines in children and adolescentsApril 29, 2022
One number could help reveal how infectious a COVID-19 patient is. Should test results include it?September 29, 2020
One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term SymptomsJuly 27, 2021
Open Letter and Notice of Liability from Doctors and Scientists to the EMA and the Members of the European Parliament Regarding COVID-19 VaccinationSeptember 13, 2021
Open letter from Florida Surgeon General to FDA Commissioner and CDC DirectorDecember 6, 2023
Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian mediaSeptember 5, 2020
Open Letter to the Honorable Xavier Becerra, Secretary of US Department of Health and Human ServicesJanuary 11, 2022
Open Letter to the MHRA Regarding Child Death Data: Signals that Covid-19 Vaccines may have caused death in children and young adultsJanuary 19, 2022
Open Letter to the World Health OrganizationMarch 6, 2021
Open Letter: Letter by NZ Doctors with Concerns Over Pfizer VaccineApril 27, 2021
Open up our country – sign the open letterJune 8, 2020
OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescentsMay 20, 2024
OpenVAERS
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled TrialJune 6, 2022
Our World in Data
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021August 6, 2021
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical TrialsFebruary 26, 2021
Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patientsOctober 30, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-upDecember 24, 2022
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin CApril 29, 2022
Package insert for Comirnaty and Pfizer-BioNTech COVID-19 VaccineRevised September 2023
Package insert for Moderna Spikevax COVID-19 VaccineRevised April 2024
Panel of doctors in Nashville, TennesseeJanuary 2022